FluoroPharma Medical, Inc. (FPMI)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Aug 14, 2026
FluoroPharma Medical Market Cap
FluoroPharma Medical has a market cap or net worth of $5.52 thousand as of August 20, 2026. Its market cap has increased by 19,596.43% in one year.
Market Cap
5.52K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since May 17, 2011, FluoroPharma Medical's market cap has decreased from 24.55M to 5.52K, a decrease of -99.98%. That is a compound annual growth rate of -42.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 5.52K | 99.96% |
| Dec 23, 2024 | 2.76K | - |
| Dec 14, 2023 | 2.76K | -94.67% |
| Dec 27, 2022 | 51.74K | 152,064.71% |
| Dec 29, 2021 | 34.00 | -99.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Therapeutic Solutions International | 7.05K |
| Entia Biosciences | 6.81K |
| Theralink Technologies | 6.15K |
| MetaStat | 5.88K |
| Hard to Treat Diseases | 5.82K |
| Better Therapeutics | 5.45K |
| LadRx | 5.45K |
| Aridis Pharmaceuticals | 5.33K |